Current  Archive  
University Hospitals Case Medical Center Implements Non-Invasive Stool-Based DNA Screening for Colorectal Cancer
Tuesday, December 23, 2008 (2253 reads)

Marlborough, MA and Cleveland, OH – (December 22, 2008) – EXACT Sciences Corporation (NASDAQ: EXAS) and University Hospitals Case Medical Center (UHCMC) of Cleveland, Ohio today jointly announced that UHCMC has launched a program for stool-based DNA (sDNA) screening within its health care system at two sites comprising fifteen physicians.  For patients unwilling or unable to obtain a colonoscopy, sDNA screening will now be the preferred method of screening offered at the sites.  UHCMC will evaluate program performance to determine broader roll-out of sDNA screening system-wide.

“Among our guiding principles is to pursue and implement breakthrough medical advancements and practices to deliver superior clinical outcomes for our patients,” said Stanton Gerson, MD, Director, Ireland Cancer Center of UHCMC, Director of Case Comprehensive Cancer Center, Case Western Reserve University.  “Our new sDNA screening initiative within UH Case Medical Center is an exciting example of this principle in action. Non-invasive sDNA screening includes the Vimentin gene, a genetic locus discovered by Dr. Sanford Markowitz of the Ireland Cancer Center and Case Western Reserve Medical School, a discovery that we believe can have a dramatic impact on increasing screening rates and decreasing mortality.”



UH Ireland Cancer CenterRead More
University Hospitals honors Barbara S. Robinson with Samuel Mather Visionary Award and Roland W. Moskowitz, MD, with Inaugural Distinguished Physician Award
Friday, December 19, 2008 (2162 reads)

CLEVELAND – University Hospitals (UH) is awarding the Samuel Mather Visionary Award to Cleveland philanthropist and civic leader Barbara S. Robinson. A UH board member since 1984, Mrs. Robinson is one the longest standing members of the University Hospitals Case Medical Center (UHCMC) Board of Directors in the history of the hospital.  She is honored for her exceptional generosity, vision and commitment as a benefactor who has had a long-lasting and profound impact on University Hospitals.

University Hospitals also is honoring Roland W. Moskowitz, MD, with the inaugural University Hospitals Distinguished Physician Award, for his significant achievements in medicine and medical research nationally.



UH Case Medical CenterRead More
University Hospitals Appoints Nathan Levitan, MD, President of UH Ireland Cancer Center, Senior Vice President of System Cancer Services
Friday, December 12, 2008 (3170 reads)

CLEVELAND – Nathan Levitan, MD, MBA, has been appointed President of the University Hospitals Ireland Cancer Center (ICC) and Senior Vice President, System Cancer Services, effective November 1, 2008.

In his new role, Dr. Levitan is responsible for cancer-related clinical program development, quality outcomes, strategic planning, and the ongoing integration of clinical trials into the ICC model of care. While working in close collaboration with Stanton Gerson, MD, Director of the Ireland Cancer Center, Dr. Levitan will oversee the continued growth of our ICC Regional Network as well as the consolidation of cancer services at UH Case Medical Center into the new UH Cancer Hospital that is scheduled to open in 2010.



UH Ireland Cancer CenterRead More
Ireland Cancer Center Researcher Finds Most Triple-Negative Breast Cancers Express MUC-1 Target
Friday, December 12, 2008 (1817 reads)

CLEVELAND – Research out of the Ireland Cancer Center of University Hospitals Case Medical Center has found that the vast majority of triple negative breast cancers express the MUC-1 target. This first-of-its-kind finding, presented today at the San Antonio Breast Cancer Symposium, has paved the way for an upcoming vaccine trial for patients with early stage triple negative breast cancer that could potentially prevent recurrence of this aggressive type of breast cancer.

Joseph Baar, MD, PhD, Director of Breast Cancer Research at the Ireland Cancer Center, and colleagues analyzed 53 tumors and determined that 92 percent of them expressed MUC-1.  These findings support their theory that this MUC-1 protein on breast cancer cells could be a target for a novel vaccine using the patient’s immune system to target and kill cancer cells.



UH Case Medical CenterRead More
Thomas F. Zenty III, University Hospitals CEO, Donates $1 Million to University Hospitals and UH Rainbow Babies & Children’s Hospital
Monday, December 01, 2008 (2942 reads)

During this season of giving, Thomas F. Zenty III, Chief Executive Officer of University Hospitals, is taking time to give back to the health system he has led over the past five years. Mr. Zenty announced a personal gift commitment of $1 million in support of University Hospitals Vision 2010 strategic plan. This generous gift, made in honor of his parents, Edna and Thomas F. Zenty, Jr., will establish two endowed funds in support of University Hospitals and UH Rainbow Babies & Children’s Hospital.



UH Rainbow Babies and Childrens HospitalRead More